Stay updated with breaking news from Katherine Crew. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In premenopausal women with early breast cancer, use of a gonadotropin-releasing hormone agonist during chemotherapy did not increase the risk of cancer recurrence for up to 12 years, according to the PROMISE-GIM6 trial.
Breast cancer doesn’t take a break when November rolls around and the pink ribbons of October’s breast cancer awareness month fade from view
Katherine Crew Overall survival for breast cancer has improved by about 40% since the 1980s, thanks to improved screening and treatments. “There are